Abstract:The title compound 4, i.e. 9-chloro-4,5-dihydro-2-ethyl-1-(2,4,6-trichlorophenyl)-1H-1,2,4-triazolo[3,2-d]- [1,5]benzoxazepinium hexachloroantimonate, is a novel 6-7-5 tricyclic heterocycle. C18H14Cl4N3O . SbCl6, M = 764.61, P2(1)/c(#14), a = 13.457(4), b = 11.583(2), c = 18.992(3) Angstrom; alpha = 90, beta = 110.11(1)degrees, Z = 4, V = 2780(1) Angstrom(3), D-c = 1.827 g/cc, mu (MoK alpha) = 19.69 cm(-1), F(000) = 1488.00, T = 293 K, R-int = 0.055 for 3094 independent reflections with I>3.00 sigma(I). The five-membered heterocyclic ring is nearly planar, with the trichlorophenyl ring at N(2) almost perpendicular to it. However, the seven-membered ring is not planar, but adopts a twist-boat conformation.

9,10,11,12-Tetrachloro-12b-hydroxy-2,12c-dimethyl-3a,5,6, 12c-tetrahydrothiazalo[4,5-c][1,4]oxazepino[5,4-a]isoindol-8-one monohydrate

9,10,11,12-Tetrachloro-12b-hydroxy-12c-phenyl-1,2,3,3a,5,6,12b,12c-octahydro-8h-cyclopenta[6,7][1,4]oxazepino[5,4-a]isoindol-8-one

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

[(E)-But-2-enoato-&#954;O]chlorido(2,2&#8242;-diamino-4,4&#8242;-bi-1,3-thiazole-&#954;2N3,N3&#8242;)zinc(II) monohydrate

2,2′-Diamino-4,4′-bi-1,3-thiazol-3,3′-diium Bis(2,2′-Diamino-4,4′-bi-1,3-thiazol-3-ium) Tetrakis(2-Nitrobenzoate)

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

[(E)-but-2-enoato-κo]chlorido(2,2′-diamino-4,4′-bi-1,3-thiazole-κ2n3,n3′)zinc(ii) Monohydrate

(2,2′-Diamino-4,4′-bi-1,3-thiazole-κ<sup>2</sup><i>N</i><sup>3</sup>,<i>N</i><sup>3′</sup>)(oxydiacetato-κ<sup>3</sup><i>O</i>,<i>O</i>′,<i>O</i>′′)copper(II) monohydrate

10-Hexyl-10<i>H</i>-phenothiazine-3-carbaldehyde

10-Hexyl-10h-phenothiazine-3-carbaldehyde

4,5,6,7-Tetrachloro-2-(2-hydroxyphenyl)-1H-isoindole-1,3(2H)-dione

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

N '-[(E)-2-hydroxybenzylidene]-5-methylisoxazole-4-carbohydrazide Monohydrate

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

4&#946;-Hydroxy-12,13-epoxytrichothec-9-ene

4,5,7-Trichloro-6-(2,4-dimethylthiazol-5-yl)-2-(3-hydroxypropyl)isoindole-1,3-dione

1,4,8,11-Tetrakis(carboxymethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetr Aazoniacyclotetradecane Tetrachloride Octahydrate

The Crystal Structure of 9‐chloro‐4,5‐dihydro‐2‐ethyl‐1‐(2,4,6‐trichlorophenyl)‐1h‐1,2,4‐triazolo[3,2‐d][1,5]‐benzoxazepinium Hexachloroantimonate

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

4,5,6,7-Tetrachloro-3-(cyclohepta-1,3,6-trien-1-yl)-3-hydroxy-2-(2-hydroxyethyl)-2,3-dihydro-1h-isoindol-1-one